stockrowClaritev Corporation
CTEV Healthcare Health Information Services
Claritev Corporation’s revenue for fiscal 2025 (year ended December 2025) was $965.4 million, up 3.74% from fiscal 2024.
- Revenue
- +6.59%
- EPS
- +8.40%
- Free cash flow
- +49.1%
- Total debt
- +0.97%
Quarter to June 2026, against a year earlier
Follow CTEV
Alert me
Claritev Corporation (CTEV) EV/Sales
As of 6 November 2026, Claritev Corporation (CTEV) trades at a EV/Sales of 5.1×. Over the past ten years it has ranged from 0.0× (December 2020) to 11.7× (June 2021); the current reading is higher than 32% of that period. That is above the Health Information Services industry median of 2.3× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 5.5× | 7.35% |
| FY2024 | 5.1× | (8.59%) |
| FY2023 | 5.6× | 18.25% |
| FY2022 | 4.7× | (30.72%) |
| FY2021 | 6.8× | (22.55%) |
| FY2020 | 8.8× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 5.3× | 3.80% |
| Mar 2026 | 5.1× | (7.31%) |
| Dec 2025 | 5.5× | (4.85%) |
| Sep 2025 | 5.7× | 1.20% |
| 22 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AMWL American Well Corporation compare | 0.1× |
| SY So-Young International Inc. Sponsored ADR compare | 0.4× |
| DH Definitive Healthcare Corp. compare | 0.4× |
| EVH Evolent Health, Inc compare | 0.6× |
| SPOK Spok Holdings, Inc. compare | 1.6× |
| NRC National Research Corporation compare | 4.6× |
| CARL Carlsmed, Inc. compare | 5.0× |
| CTEV Claritev Corporation | 5.1× |
| SOPH SOPHiA GENETICS SA compare | 6.2× |
| Health Information Services industry median | 2.3× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)